Study: 26% of C. Diff Patients Received Only Unnecessary Antimicrobials
Infection Control and Hospital Epidemiology.
Researchers studied 246 patients with new-onset CDI diagnosed at Minneapolis Veterans Affairs Medical Center from January 2004 through December 2006. Two infectious disease physicians evaluated the use of non-CDI antimicrobials (those that are inactive against C. diff), which they defined as unnecessary if not fully indicated.
Data showed 57 percent of patients received non-CDI antimicrobials during and/or after their CDI treatment, and 77 percent received at least one unnecessary antimicrobial dose. Twenty-six percent of patients received only unnecessary antimicrobials.
More Articles on C. diff:Quidel Receives FDA Clearance for Handheld Molecular Diagnostic Test for C. Difficile
Illinois Publishes C. Diff, MRSA Data From Lab Tests for First Time
Study: Dog Correctly Detected C. Difficile in Patients
© Copyright ASC COMMUNICATIONS 2015. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
New From Becker's Infection Control & Clinical Quality
The Joint Commission: 10 most frequently identified root causes of sentinel eventsRead Now
- Growing a healthcare IT company for ASCs — Key thoughts from Source Medical's Dr. James Coffin
- Are quality measures improving patient safety? 7 key notes
- National Surgical Centers of America earns AAAHC accreditation
- GI physician leader to know: Dr. Joseph Kittinger of Wilmington Gastroenterology
- PPI therapy may increase risk of kidney injury in elderly